VERTEX PHARMACEUTICALS INC / MA Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $31.90 million as of 2014-03-31, per its 10-Q filed 2014-05-05.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2014-05-05
- 2014-03-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $31.90M.
- 2013-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $31.90M.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2014-03-31 | $31.90M 10-Q · filed 2014-05-05 |
| 2013-06-30 | $31.90M 10-K · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |